David Henry Mack - Aug 7, 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: President and CEO, Director
Signature: /s/ David H. Mack
Stock symbol: PMVP
Transactions as of: Aug 7, 2023
Transactions value $: $45,315
Form type: 4
Date filed: 8/8/2023, 04:43 PM
Previous filing: May 15, 2023
Next filing: Nov 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Options Exercise	$45.3K	+85.5K	+106.92%	$0.53^*	165K	Aug 7, 2023	Direct
holding	PMVP	Common Stock						148K	Aug 7, 2023	See footnote	F1
holding	PMVP	Common Stock						80K	Aug 7, 2023	See footnote	F2
holding	PMVP	Common Stock						57K	Aug 7, 2023	See footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Options Exercise	$0	-85.5K	-21.74%	$0.00	308K	Aug 7, 2023	Common Stock	85.5K	$0.53	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2	The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3	The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4	The shares subject to the option are fully vested and immediately exercisable.